Metabolic Research
Tirzepatide
Strength · 5mg
For research use onlyStrength
Price · Single vial (AUD)
$109
$60
AUDLimited research allocation
Pre-release pricing applied automatically at checkout
- AU-based fulfilment
- Discreet dispatch
- Tracking provided
- Secure checkout
Crypto settlement available at checkout.
Research Information
Compound profile
Neutral, scientific reference information provided for laboratory research contexts only.
Short Description
A dual GIP and GLP-1 receptor agonist peptide studied in laboratory metabolic research.
Research Overview
Examined in in vitro and preclinical research for its co-agonist interaction with the GIP and GLP-1 receptors.
Mechanism of Interest
Engineered peptide investigated for combined activation of GIP and GLP-1 class B G-protein-coupled receptors and downstream cAMP-mediated signalling.
Key Research Areas
- Dual incretin receptor binding studies
- Comparative co-agonist pharmacology
- In vitro signalling assays
- Preclinical metabolic pathway research
Compliance Notice
For research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease.
Complete Your Research Set
Build a coordinated research set
Base Selection
Already selected
Common Research Pairing
Pre-selected
Extended Research Set
Optional
Selected Total
$113 AUD
For research use only. Items listed at standard AUD pricing — base product pricing is unchanged. Adjust the selection to suit your laboratory requirements.
Research Use Only. This product is supplied for laboratory research purposes only. Not intended for human or animal consumption, medical use, diagnostic use, therapeutic use, or performance enhancement.
Related research compounds
You may also research
Tirzepatide
$60 AUD